STI 0.00% 0.2¢ stirling products limited

stirling pharma awarded canada site license

  1. 3,448 Posts.
    lightbulb Created with Sketch. 809
    It begins, expect announcement today.

    Articles: Stirling Pharma Inc Awarded Canada Site License
    Submitted by amandamacpherson on Oct 14, 2010 - 10:12 AM

    Located in Cape Breton, Nova Scotia, Stirling Pharma Inc is an emerging pharmaceutical company that aspires to provide solutions that have a significant positive impact on the health of the companies and people we serve. Your wellbeing is our priority. Today, Stirling Pharma Inc. has advised that is has been issued a site license for natural health products by Health Canada.

    Stirling Pharma Awarded Health Canada Site License

    Nova Scotia, Canada (October 14, 2010) - Stirling Pharma Inc, a wholly owned subsidiary of Australian listed Stirling Products Ltd (ASX:STI), today advises that the company has been issued a site license by Health Canada's Minister of Health under the authority of the Natural Health Products Regulations for the manufacturing, packaging and labeling of natural health products at its manufacturing facility located in North Sydney, Nova Scotia.

    The issuance of this license permits the North Sydney facility to manufacture supplments and natural health products.

    The company further advises that Health Canada has advised that an inspection for the issue of an Established License has been scheduled over a number of days commencing 29 November 2010. Following this inspection a full Establishment License is expected to issue that will then allow Stirling Pharma to manufacture pharmaceutical drugs.

    The 46,000 sq. ft. North Sydney facility includes laboratories for formulation development and includes specialist sections having various capabilities such as high shear mixing, container blending and equipment for modified drug relase technology. The facility provides formulation development and testing services, as well as provision for the manufacture amd packaging of products in solid and liquid soage forms. With current fit-out and configuration the plant has an annual capacity to manufacture and package over 550 million tablets, 5 million bottles and blend up to 1.5 million kg of product.

    About Stirling Pharma Inc.

    Located in Cape Breton, NS, Stirling Pharma Inc. is a subsidiary of Stirling Products Ltd. Australia. Stirling Pharma operates a 46,000 sq. ft. GMP pharmaceutical facility committed to the manufacture and commericalization of prescription, over-the-counter, nutraceutical and natural health products.

    For further information see www.stirlingpharmainc.com or contact:

    Wayne Miller

    Vice President, Sales and Marketing

    Stirling Pharma Inc.

    T: +1 902 794 8237

    E: [email protected]

    link:
    http://www.wireservice.ca/index.php?module=News&func=display&sid=3494
 
watchlist Created with Sketch. Add STI (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.